1. Home
  2. ALKS vs TFSL Comparison

ALKS vs TFSL Comparison

Compare ALKS & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • TFSL
  • Stock Information
  • Founded
  • ALKS 1987
  • TFSL 1938
  • Country
  • ALKS Ireland
  • TFSL United States
  • Employees
  • ALKS N/A
  • TFSL N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • TFSL Savings Institutions
  • Sector
  • ALKS Health Care
  • TFSL Finance
  • Exchange
  • ALKS Nasdaq
  • TFSL Nasdaq
  • Market Cap
  • ALKS 4.9B
  • TFSL 4.0B
  • IPO Year
  • ALKS 1991
  • TFSL 2007
  • Fundamental
  • Price
  • ALKS $29.71
  • TFSL $12.69
  • Analyst Decision
  • ALKS Buy
  • TFSL Hold
  • Analyst Count
  • ALKS 12
  • TFSL 3
  • Target Price
  • ALKS $35.42
  • TFSL $14.33
  • AVG Volume (30 Days)
  • ALKS 1.7M
  • TFSL 334.5K
  • Earning Date
  • ALKS 02-13-2025
  • TFSL 01-28-2025
  • Dividend Yield
  • ALKS N/A
  • TFSL 8.88%
  • EPS Growth
  • ALKS 55.25
  • TFSL 7.69
  • EPS
  • ALKS 1.97
  • TFSL 0.28
  • Revenue
  • ALKS $1,505,121,000.00
  • TFSL $304,660,000.00
  • Revenue This Year
  • ALKS N/A
  • TFSL N/A
  • Revenue Next Year
  • ALKS N/A
  • TFSL $7.19
  • P/E Ratio
  • ALKS $13.00
  • TFSL $45.50
  • Revenue Growth
  • ALKS N/A
  • TFSL N/A
  • 52 Week Low
  • ALKS $22.90
  • TFSL $11.70
  • 52 Week High
  • ALKS $32.88
  • TFSL $15.25
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 49.52
  • TFSL 32.80
  • Support Level
  • ALKS $29.65
  • TFSL $12.54
  • Resistance Level
  • ALKS $31.18
  • TFSL $13.48
  • Average True Range (ATR)
  • ALKS 0.87
  • TFSL 0.28
  • MACD
  • ALKS -0.16
  • TFSL -0.14
  • Stochastic Oscillator
  • ALKS 20.38
  • TFSL 13.45

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

Share on Social Networks: